Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 5Dermatologic 4Head & Neck 1

Conditions

Mouth Neoplasms 3Leukoplakia, Oral 2Head and Neck Neoplasms 2Squamous Cell Carcinoma of Head and Neck 1Skull Base Neoplasms 1Precancerous Conditions 1Oropharyngeal Neoplasms 1Neoplasms 1Nasopharyngeal Neoplasms 1Lichen Planus, Oral 1Leukoplakia 1Laryngeal Neoplasms 1Hypopharyngeal Neoplasms 1Erythroplasia 1Carcinoma in Situ 1

Interventions

Cetuximab 3Biopsy 3Radiotherapy, Intensity-Modulated 2Immunohistochemistry 2Gene Expression Profiling 2Cisplatin 2vandetanib 1sintilimab 1Video-Assisted Surgery 1Photochemotherapy 1Paclitaxel 1Nivolumab 1Dihematoporphyrin Ether 1Comparative Genomic Hybridization 1Celecoxib 1Aspirin 1Aminolevulinic Acid 1Albumin-Bound Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Precancerous Conditions × Aminolevulinic Acid × Head & Neck × Clear all
NCT00978081 2019-04-23

Photodynamic Therapy in Treating Patients With Premalignant or Early Stage Head and Neck Tumors

Abramson Cancer Center at Penn Medicine

Phase 1 Completed
35 enrolled
Head & NeckOther neoplasm

Head and Neck Neoplasms, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Nasopharyngeal Neoplasms, Oropharyngeal Neoplasms, Precancerous Conditions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡